We thus analyzed GALNT14 mRNA levels by qPCR, that resulted expressed in 11/15 (73.3%) NB cell lines and 18/76 (23.7%) NB patients (Figure 4A, 4B). The gene discussed is GALNT14; the disease is neuroblastoma.